Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database 

References

• Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165–182. doi:10.1001/jama.2016.19043
   PubMed Web of Science ®Google Scholar
• Gakidou E, Afshin A, Abajobir AA, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1345–1422. doi:10.1016/S0140-6736(17)32366-8
   PubMed Web of Science ®Google Scholar
• Forouzanfar MH, Afshin A, Alexander LT, GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1659–1724. doi:10.1016/S0140-6736(16)31679-8
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
   PubMed Web of Science ®Google Scholar
• Mancia G, Messerli F, Bakris G, Zhou Q, Champion A, Pepine CJ. Blood pressure control and improved cardiovascular outcomes in the international verapamil SR-trandolapril study. Hypertension. 2007;50(2):299–305. doi:10.1161/HYPERTENSIONAHA.107.090290
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim S-H, Kang S-H, et al. Blood pressure control and cardiovascular outcomes: real-world implications of the 2017 ACC/AHA hypertension guideline. Sci Rep. 2018;8(1):13155. doi:10.1038/s41598-018-31549-5
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357. doi:10.1097/01.hjh.0000431740.32696.cc
   PubMed Web of Science ®Google Scholar
• Laurent S. Antihypertensive drugs. Pharmacol Res. 2017;124:116–125. doi:10.1016/j.phrs.2017.07.026
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014;311(5):507. doi:10.1001/jama.2013.284427
   PubMed Web of Science ®Google Scholar
• Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the centers for disease control and prevention. Hypertension. 2014;63(4):878–885. doi:10.1161/HYP.0000000000000003
   PubMed Web of Science ®Google Scholar
• Yiannakopoulou E, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12(3):243–249. doi:10.1097/00149831-200506000-00010
   PubMedGoogle Scholar
• Lee HJ, Jang S-I, Park E-C. Effect of adherence to antihypertensive medication on stroke incidence in patients with hypertension: a population-based retrospective cohort study. BMJ Open. 2017;7(6):e014486. doi:10.1136/bmjopen-2016-014486
   Web of Science ®Google Scholar
• Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.0575
   PubMed Web of Science ®Google Scholar
• Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence in hypertension. Front Pharmacol. 2017;8:100. doi:10.3389/fphar.2017.00100
   PubMed Web of Science ®Google Scholar
• Sabaté E, World Health Organization, editors. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003. 198.
   Google Scholar
• Ambaw AD, Alemie GA, Yohannes SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12(1):282. doi:10.1186/1471-2458-12-282
   Web of Science ®Google Scholar
• Lima-Dellamora ED, Osorio-de-Castro CG, Madruga LG, et al. Use of pharmacy records to measure treatment adherence: a critical review of the literature. Cad Saude Publica. 2017;33(3):e00136216.
   Web of Science ®Google Scholar
• Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565–574. doi:10.1002/pds.1230
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047
   PubMed Web of Science ®Google Scholar
• Sung S-K, Lee S-G, Lee K-S, Kim D-S, Kim K-H, Kim K-Y. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review. Clin Ther. 2009;31(6):1309–1320. doi:10.1016/j.clinthera.2009.06.011
   PubMed Web of Science ®Google Scholar
• Han E, Suh D-C, Lee S-M, Jang S. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study. Res Soc Adm Pharm. 2014;10(6):e87–98. doi:10.1016/j.sapharm.2014.02.001
   PubMed Web of Science ®Google Scholar
• Schulz M, Krueger K, Schuessel K, et al. Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients. Int J Cardiol. 2016;220:668–676. doi:10.1016/j.ijcard.2016.06.263
   PubMed Web of Science ®Google Scholar
• Johnsrud M,W, Schafermeyer K. Measuring adherence and persistence in drug therapy. JMCP. 2002;8(3):205–206. doi:10.18553/jmcp.2002.8.3.204
   Google Scholar
• Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014;2(1):3. doi:10.1186/2047-2501-2-3
   PubMedGoogle Scholar
• Wong MCS, Jiang JY, Griffiths SM. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol. 2010;50(5):598–605. doi:10.1177/0091270009346058
   Web of Science ®Google Scholar
• Piercefield EW, Howard ME, Robinson MH, Kirk CE, Ragan AP, Reese SD. Antihypertensive medication adherence and blood pressure control among central Alabama veterans. J Clin Hypertens. 2017;19(5):543–549. doi:10.1111/jch.12953
   Web of Science ®Google Scholar
• Tsiantou V, Pantzou P, Pavi E, Koulierakis G, Kyriopoulos J. Factors affecting adherence to antihypertensive medication in Greece: results from a qualitative study. Patient Prefer Adherence. 2010;7(4):335–343. doi:10.2147/PPA.S12326
   Web of Science ®Google Scholar
• Tilea I, Petra D, Voidazan S, Ardeleanu E, Varga A. Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania. Patient Prefer Adherence. 2018;24(12):625–635. doi:10.2147/PPA.S162965
   Web of Science ®Google Scholar
• Wong MCS, Jiang JY, Griffiths SM. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study. J Epidemiol Community Health. 2010;64(10):895–901. doi:10.1136/jech.2009.091603
   Web of Science ®Google Scholar
• Brown MJ. Hypertension and ethnic group. BMJ. 2006;332(7545):833–836. doi:10.1136/bmj.332.7545.833
   Web of Science ®Google Scholar
• van Wijk BLG, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens. 2008;26(1):145–153. doi:10.1097/HJH.0b013e32826308b4
   Web of Science ®Google Scholar
• Public Policy Committee. International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP): guidelines for good pharmacoepidemiology practice. Pharmacoepidemiol Drug Saf. 2016;25(1):2–10. doi:10.1002/pds.3891.
   PubMed Web of Science ®Google Scholar
• Swart E, Gothe H, Geyer S, et al. Gute Praxis Sekundärdatenanalyse (GPS): leitlinien und Empfehlungen. Gesundheitswesen. 2015;77(02):120–126. doi:10.1055/s-0034-1396815
   Web of Science ®Google Scholar
• The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on Methodological Standards in Pharmacoepidemiology (Revision 7). 2018. EMA/95098/2010.
   Google Scholar
• de Kraker MEA, Abbas M, Huttner B, Harbarth S. Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions. Clin Microbiol Infect. 2017;23(11):819–825. doi:10.1016/j.cmi.2017.05.019
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Holt E, Joyce C, et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report. J Hypertens. 2015;33(2):412–420. doi:10.1097/HJH.0000000000000382
   PubMed Web of Science ®Google Scholar
• Fairman KA, Matheral B. Evaluating medication adherence: which measure is right for your program? J Manag Care Spec Pharm. 2000;6(6):499–506.
   Google Scholar
• Burke TA, Sturkenboom MC, Lu S, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006;24(6):1193–1200. doi:10.1097/01.hjh.0000226211.95936.f5
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Mantovani LG, Sturkenboom MCJM, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005;23(11):2093–2100. doi:10.1097/01.hjh.0000186832.41125.8a
   PubMed Web of Science ®Google Scholar
• Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens. 2002;16(8):569–575. doi:10.1038/sj.jhh.1001451
   PubMed Web of Science ®Google Scholar
• Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007;20(1):72–80. doi:10.3122/jabfm.2007.01.060094
   PubMed Web of Science ®Google Scholar
• Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep. 2000;2(6):515–524. doi:10.1007/s11906-996-0035-6
   Google Scholar
• Marentette MA, Gerth WC, Billings DK, Zarnke KB. Antihypertensive persistence and drug class. Can J Cardiol. 2002;18(6):649–656.
   PubMed Web of Science ®Google Scholar
• Mancia G, Zambon A, Soranna D, Merlino L, Corrao G. Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data. J Hypertens. 2014;32(8):1708–1715. doi:10.1097/HJH.0000000000000222.
   PubMed Web of Science ®Google Scholar
• Maimaris W, Paty J, Perel P, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. Caulfield MJ, editor. 2013;10(7):e1001490. doi:10.1371/journal.pmed.1001490.
   Web of Science ®Google Scholar
• Li Y, Wang JL, Zhang XC, et al. Effectiveness of adherence to standardized hypertension management by primary health care workers in China: a cross-sectional survey 3 years after the healthcare reform. Biomed Environ Sci BES. 2016;29(12):915–921. doi:10.3967/bes2016.123
   Web of Science ®Google Scholar
• Zhang Y, Li X, Mao L, et al. Factors affecting medication adherence in community-managed patients with hypertension based on the principal component analysis: evidence from Xinjiang, China. Patient Prefer Adherence. 2018;12:803–812. doi:10.2147/PPA.S158662
   Web of Science ®Google Scholar
• Krueger K, Botermann L, Schorr SG, Griese-Mammen N, Laufs U, Schulz M. Age-related medication adherence in patients with chronic heart failure: a systematic literature review. Int J Cardiol. 2015;1(184):728–735. doi:10.1016/j.ijcard.2015.03.042
   Web of Science ®Google Scholar
• Basheti IA, Hait SSE, Qunaibi EA, Aburuz S, Bulatova N. Associations between patient factors and medication adherence: a Jordanian experience. Pharm Pract. 2016;14(1):639. doi:10.18549/PharmPract.2016.01.639
   PubMedGoogle Scholar
• Liao Y, Gilmour S, Shibuya K, Kokubo Y. Health insurance coverage and hypertension control in China: results from the China health and nutrition survey. PLoS One. 2016;11(3):e0152091. doi:10.1371/journal.pone.0152091
   PubMed Web of Science ®Google Scholar